Tandem Diabetes Care Inc (FRA:TD5A)
€ 45.71 -1.06 (-2.27%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.82 GF Score: 78/100

Tandem Diabetes Care Inc at UBS Global Healthcare Virtual Conference Transcript

May 24, 2021 / 04:00PM GMT
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Good morning. Thanks, everybody, for joining us for this next session. And I am Matt Taylor, UBS' U.S. Medical Supplies and Devices analyst. For this session, I'm pleased to be joined by management from Tandem Diabetes. And like our other sessions, this is going to include mostly fireside chat. We have lots of questions prepared. But if there's any that you would like to get in, you can e-mail me or use the question feature at the bottom of the screen.

And to kick things off for this session, we're going to have a few slides from Tandem management. I'm joined by both John Sheridan, who's the President and CEO; and Leigh Vosseller, who's the EVP and CFO of the company. So John and Leigh, thanks so much for joining us. Really appreciate your time today. And I just want to turn the floor over to you, John, to get started.

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Great. Thanks, Matt. It's great to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot